Earlier this month, the Food and Drug Administration (FDA) made a reckless decision to approve Florida’s plan to import certain prescription medicines from Canada. Here are some recent articles highlighting the chorus of people and organizations concerned about the feasibility of this plan as well as the opportunity drug importation creates for unsafe drugs finding their way into the hands of patients:
- Aaron Kesselheim, professor at Harvard Medical School: “I think it's going to be hard for states to import drugs like that in any kind of scale that would make a difference in terms of lowering prices for patients.” FDA for the first time approves plan to import drugs, Axios
- Nicholas Bagley, law professor at University of Michigan: “There is a yawning gap between the public enthusiasm for Canadian drug imports and the consensus view from experts that it's a daft approach.” FDA for the first time approves plan to import drugs, Axios
- Amir Attaran, law professor at University of Ottawa: “Canada has about the same population as California, and we simply do not have the supply for a country nine times larger than ours without provoking massive drug shortages here.” Canada frets over FDA allowing Florida to import prescription drugs, The Washington Times
- Chris Meekins, an analyst at Raymond James and a former Health and Human Services official during the Trump administration: “I think this being perceived as a panacea to lower drug costs in Florida and elsewhere is wishful thinking by politicians and will not materialize in the way that they have portrayed to the public.” Florida scores drug import win – but many hurdles remain, The Hill
- Stacie Dusetzina, health-policy professor at Vanderbilt University School of Medicine: “There are real constraints on Canada’s ability to even do this, they would basically be giving up drugs that are meant for their population to subsidize drugs for people in Florida, which is not politically reasonable to be asking from people in Canada.” Florida Is First State Allowed to Import Drugs From Canada in Bid to Reduce Costs, The Wall Street Journal
- Adrian Dix, British Columbia's health minister: “This is effectively a raid on Canada's drug supply." B.C. health minister says he expects Ottawa to protect Canadians from drug shortages, CBC
- Craig Garthwaite, professor and director of healthcare at Northwestern University’s Kellogg School of Management: The policy is “more politics and sound bites than it is actual sound drug policy.” Drug pricing experts skeptical that Florida's drug import plan will work, Endpoints News
- Mark Holland, Canada’s Minister of Health: "There is no way we will allow any jurisdiction, be it a state or another foreign jurisdiction, to endanger the Canadian drug supply. That is not an appropriate solution to whatever challenges they may be facing. We're going to do everything in our power to make sure that another country cannot be given the ability to pillage our health system for its own benefit." Federal health minister says he won't allow Florida to 'pillage' the drug supply, CBC
Learn more about our concerns with drug importation.
Gabby Migliara
Gabby Migliara is a director of Public Affairs at PhRMA focusing on internal communications and PhRMA’s digital presence, including maintaining this website and executive social presence. She previously worked with the U.S. Census Bureau on marketing and communications for the 2020 Census campaign. Outside the office, Gabby enjoys trying new restaurants, hanging with her cat and exploring D.C. neighborhoods.
Florida’s importation plan puts patients in danger
ICYMI: Antimicrobial resistance spotlighted as growing public health threat
Why drug importation is bad for Americans
PhRMA submits comments on FDA’s proposed rule on drug importation
Drug importation: An old idea that is still a bad idea
What they’re saying: Safety is top concern for recent drug importation proposal
ICYMI: Canadian government, stakeholders voice concerns with drug importation proposals
PhRMA responds to Florida’s request for information on drug importation
PhRMA CEO raises concerns with Florida importation proposal, highlights reforms needed to lower costs for patients
Look at the facts. Drug importation is dangerous.
Why state drug importation pilot programs don’t work
ICYMI: Wall Street Journal highlights dangers of counterfeit medicines entering the United States through drug importation
Former law enforcement officials raise concerns with drug importation proposals
The risks of counterfeit imported medicines
Resources for understanding the dangers of drug importation
ICYMI: What the experts are saying about importation
How drug importation schemes could increase U.S. law enforcement burdens
Case Study: How one online pharmacy knowingly endangered U.S. consumers
Why drug importation threatens patient safety
Fact Check Friday: The truth about drug importation and patient safety
What you don’t know about importation from Canada
Discovery of counterfeit hepatitis C drug is another example of why importation is bad for patients
What they are saying: Florida Drug Importation Program is Unfeasible and Dangerous
Drug Importation
Importation
What they are saying: Florida Drug Importation Program is Unfeasible and Dangerous
What they are saying: Florida Drug Importation Program is Unfeasible and Dangerous